Atlas Trials

Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

Clinical trial NCT00630253 · COMPLETED

Trial details

NCT number
NCT00630253
Sponsor
Masonic Cancer Center, University of Minnesota
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fanconi Anemia
Start date
2000-02-17
Primary completion
2020-10-10
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.